Research Background & Mechanism
Semaglutide (GLP-1 receptor agonist) is a GLP-1 receptor agonist with a molecular weight of 4113.6 Da. Understanding its mechanism — activates the GLP-1 receptor to modulate glucose handling and appetite signalling in metabolic research models — matters because it defines which experimental models the peptide is suited for and which controls a lab should run.
For researchers designing a protocol, the practical takeaway is to match the peptide to a specific, testable hypothesis rather than to a broad research area. Semaglutide (GLP-1 receptor agonist) is most consistently cited in work on metabolic regulation, glucose homeostasis, satiety signalling, so that is where the published literature will give you the most guidance.
Purity & Quality Standards
The baseline specification for Semaglutide should be ≥98% by HPLC with MS confirmation. High-performance liquid chromatography reports the purity percentage, while mass spectrometry confirms that the material is actually Semaglutide (GLP-1 receptor agonist) at the expected molecular weight (4113.6 Da) — the two checks are complementary, not redundant.
Beyond purity, verify the salt form and any residue from synthesis (such as TFA removal) on the certificate of analysis. These details are easy to overlook but can shift results in sensitive assays, so they are part of any serious supplier-verification checklist.
Storage & Handling
The correct storage condition for Semaglutide is lyophilized at -20°C, stable 12–24 months. Lyophilized peptide held at this temperature keeps its stated purity far longer than material left at ambient temperature, and the difference is measurable over months of routine use.
Once reconstituted, stability drops quickly, so laboratories should refrigerate solutions and use them within the window defined by their own protocol. Plan reconstitution just before use rather than in advance.
Sourcing & Supplier Verification
A reliable Semaglutide supplier should provide a batch-specific COA showing HPLC ≥98% and an MS spectrum at 4113.6 Da, and should be transparent about synthesis capacity and lead times. Suppliers that cannot produce these documents are the primary source of sub-standard or mis-identified material.
For bulk research purchasing, request the COA before committing to a large order, and confirm the peptide is sold strictly for laboratory and research use. A supplier that markets research peptides with therapeutic language is a red flag for compliance.
Frequently Asked Questions
Q1: What is Semaglutide used for in research?
In laboratory models it is used to study GLP-1 receptor activation and its downstream effects on glucose handling and energy intake — never for human or clinical use.
Q2: Is Semaglutide the same as the prescription drug?
Semaglutide is a research peptide; the branded pharmaceutical is a separate, regulated product. Research material must not be conflated with any therapeutic product.
Q3: What purity and documentation should I require?
≥98% HPLC plus MS confirmation and a batch COA; verify the C18 fatty-acid modification is stated on the certificate.
Important: All products are sold strictly for laboratory and research purposes only — not for human or veterinary use. No medical, therapeutic, or dosing guidance is provided or implied. Researchers are responsible for compliance with their institution and local regulations.
📞 WhatsApp: +852 4419 8097 — batch-specific COA documents, bulk research pricing, and current stock for your lab.